PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...
PISCATAWAY, N.J., March 26, 2025 /PRNewswire/ -- GenScript Biotech Corporation (GenScript), a global leader in life sciences research, manufacturing technologies and production services, has been ...
(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...
BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of TurboCHOâ„¢ Protein Expression Kit, a next-generation antibody expression reagent designed to set a new ...
The rapid advancements in cancer immunotherapy have positioned bispecific antibodies (BsAbs) and T-cell engagers (TCEs) as transformative therapeutic strategies. However, the development of these ...
In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy ...
Join us as we delve into the forefront of SARS-CoV-2 diagnostics and GenScript's transformative impact in the fight against COVID-19. We'll discuss the emergence of COVID-19 and GenScript's rapid ...
GenScript USA Inc. opened an automated gene synthesis and plasmid preparation facility in Piscataway near its U.S. headquarters on Nov. 2. The opening of the more than 50,000-square-foot facility ...
Shares of Genscript Biotech jumped 20 per cent after the company said the government had accepted its application for running clinical trials for its blood cancer treatment. The company, one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results